Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial Antibiotics
The uncontrolled spread of drug-resistant tuberculosis (DR-TB) clinical cases necessitates the urgent discovery of newer chemotypes with novel mechanisms of action. Here, we report the chemical synthesis of rationally designed novel transition-state analogues (TSAs) by targeting the cyclization (Cy)...
Main Authors: | Mousumi Shyam, Gourab Bhattacharje, Chris Daniel, Amrendra Kumar, Pragya Yadav, Piyali Mukherjee, Samsher Singh, Amit Kumar Das, Tadigoppula Narender, Amit Singh, Venkatesan Jayaprakash, Sanjib Bhakta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/24/8115 |
Similar Items
-
Design, Development, and In Silico Study of Pyrazoline-Based Mycobactin Analogs as Anti-Tubercular Agents
by: Gourav Rakshit, et al.
Published: (2021-11-01) -
Designing and In Silico Evaluation of Some Non-Nucleoside <i>MbtA</i> Inhibitors: On Track to Tackle Tuberculosis
by: Gourav Rakshit, et al.
Published: (2022-11-01) -
Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents
by: Matteo Mori, et al.
Published: (2021-02-01) -
Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections
by: Matteo Mori, et al.
Published: (2022-08-01) -
The Mycobacterium abscessus mbtE Analog MAB_2122 Is, in Contrast to the mbtE Analog MAB_2248c, Dispensable for Normal Growth in Low-Iron Conditions
by: Mark Foreman, et al.
Published: (2023-02-01)